-
October 10, 2017PREVIEW
A new tool with six patient-specific inputs was created, validated, and shown to be useful in identifying the 12-month risk of hypoglycemia-related emergency department (ED) or hospitalization...
-
August 28, 2017PREVIEW
Use of canagliflozin (Invokana—Janssen) in patients with type 2 diabetes who had established cardiovascular (CV) disease or CV risk factors resulted in a 14% reduction in the composite endpoint of...
-
June 20, 2017PREVIEW
Use of pioglitazone, an oral thiazolidinedione antihyperglycemic agent, was associated with an increased risk of bone fractures in insulin-resistant, nondiabetic patients with a recent history of...
-
May 16, 2017PREVIEW
Use of once-daily lixisenatide (Adlyxin—Sanofi-Aventis) in older, nonfrail patients whose type 2 diabetes (T2D) was not controlled on their current antidiabetic regimen resulted in improvements in...
-
March 27, 2017PREVIEW
A new position statement by the American Diabetes Association (ADA) focuses on prevention, screening, and management of several diabetic neuropathies, including distal symmetric polyneuropathy (...
Pages
